A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)

NCT04498247 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
263
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated based on an interim assessment of immunogenicity

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC